The New York Times reports:
The Biden administration is planning to give Americans age 50 or older the option of a second booster of the Pfizer-BioNTech or Moderna coronavirus vaccine without recommending outright that they get one, according to several people familiar with the plan.
Major uncertainties have complicated the decision, including how long the protection from a second booster would last, how to explain the plan to the public and even whether the overall goal is to shield Americans from severe disease or from less serious infections as well, since they could lead to long Covid.
Read the full article.
Update: The Biden administration plans to offer second booster shots to those 50 or older. The FDA could authorize the doses next week. https://t.co/KjXCT0cgxH
— The New York Times (@nytimes) March 26, 2022